Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford has a large concentration of Global Health (GH) and tropical healthcare activities, comprising diverse world-class research undertaken by its researchers based in both Oxford and its long-established Wellcome-funded overseas research and capacity-building programmes in Africa and Asia (MORU, KEMRI and OUCRU). 

The outputs and outcomes from GH research are broad reaching, bringing significant impact across all academic disciplines of medicine, the physical and life sciences, social sciences and humanities. The overseas centres provide comprehensive clinical and public health research programmes entirely focussed on the discovery and development of appropriate, practical, affordable interventions that measurably improve the health of people living in resource-limited parts of the world.

Mahidol Oxford Tropical Medicine Research Unit (MORU), with its integrated, highly collaborative and flexible network of 5 research units and 50 sites across South East Asia, supports and conducts targeted patient-centred research addressing global and regional health problems. Current research strengths are the development of effective and practical means of diagnosing and treating tropical and infectious diseases.

Through this pilot call, MORU and the TRO aim to facilitate closer interactions between MORU- and Oxford-based teams that will support and mutually benefit global health research initiatives being led out of either location. The focus will be on diagnostic devices for tropical and infectious diseases, with the goal of driving more translational research initiatives in global health.

Introduction to “Diagnostics in Tropical and Infectious Diseases (DiTi)”

This is in collaboration with Mahidol Oxford Translational Innovation Partnership (MOTIP), funded by Wellcome IP Revenue Retention funds, and the institution translational partnership award (iTPA) by Wellcome (MORU, based in Bangkok, Thailand). This call aims to strengthen the long-term partnership between Oxford University and our host institute, the Faculty of Tropical Medicine (FTM), Mahidol University through the newly established tropical medicine diagnostic development centre (Tropmed_DC). The call will look to establish partnerships and support collaborative projects around the priority areas of novel diagnostics tools targeting development of the tropical healthcare setting. Oxford employed PIs based in Oxford (UK) or MORU Tropical Health Network (Thailand) are encouraged to apply with at least one PI being based in Oxford, UK.

Technologies supported can span from early stages of prototyping to requiring further validation towards implementation in the clinical setting and thus would benefit from on the ground testing in relevant patient populations and global health settings.

Appendices 1 and 2 provide two different representations of the translational pathway and some examples of translational research activities that align with each stage (please note these lists are non-exhaustive). The MORU-Oxford DiTi call will support projects that are beyond stage D1 (Appendix 1) and TRL 1 (Appendix 2). If you require accessible appendices please contact Kavita S Subramaniam.